Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
4 pending office actions • 2 art units • 3 examiners • 0 of 4 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Winfield Solutions LLC manages a patent portfolio in the Biotechnology & Pharmaceuticals technology area with 3 pending office actions. These actions are distributed among 3 distinct examiners. The prosecution activity takes place across 2 distinct art units, indicating that the company's biotechnology filings are being reviewed by more than one specialized technical group. The involvement of 2 distinct art units within the Biotechnology & Pharmaceuticals field suggests that the company's innovations cover different technical niches.
CABRAL, ROBERT S is the busiest examiner for the company, currently managing 1 pending office action. Because there are 3 pending actions and 3 distinct examiners, each examiner is responsible for exactly 1 action. This shows an even distribution of the workload among CABRAL, ROBERT S and two other officials. The 3 to 3 ratio of actions to examiners means that each pending application is receiving a unique review from a different individual at the patent office. This distribution provides a variety of examiner perspectives on the company's intellectual property.
Practitioners must navigate the specific standards of 2 different units while dealing with 3 different examiners. This profile represents a balanced prosecution environment where individual examiner attention is maintained across multiple technical departments. The involvement of 2 distinct art units suggests that the company's innovations touch upon different sub-specialties within the Biotechnology & Pharmaceuticals sector. This data provides a baseline for future filings, as any expansion in the portfolio will likely introduce new examiners or art units.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (50%) |
| Double-patenting + other | 1 (25%) |
| Multi-statute (no §101) | 1 (25%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CABRAL, ROBERT S | 2 | 62.6% | +32.5% |
| FAY, ZOHREH ALEMZADEH | 1 | 52.2% | -6.2% |
| GERIDO, DWAN A | 1 | 58.0% | +30.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18886715 | DRIFT REDUCTION ADJUVANT COMPOSITIONS AND METHODS OF USING SAME | CABRAL, ROBERT S | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18348543 | SOIL-BASED DNA EXTRACTION | GERIDO, DWAN A | 9d |
| 18886715 | DRIFT REDUCTION ADJUVANT COMPOSITIONS AND METHODS OF USING SAME | CABRAL, ROBERT S | — |
| 18829439 | DRIFT REDUCTION ADJUVANT COMPOSITIONS AND METHODS OF USING SAME | CABRAL, ROBERT S | — |
| Art Unit | Apps |
|---|---|
| 1617 | 1 |
| 1797 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18886715 | DRIFT REDUCTION ADJUVANT COMPOSITIONS AND METHODS OF USING SAME | CABRAL, ROBERT S | — | §102§103§112Other | Non-Final OA | — | Pending | Sep 16, 2024 |
| 18829439 | DRIFT REDUCTION ADJUVANT COMPOSITIONS AND METHODS OF USING SAME | CABRAL, ROBERT S | — | §103§112DP | Non-Final OA | — | Pending | Sep 10, 2024 |
| 18543825 | MULTIFUNCTIONAL AGRICULTURAL ADJUVANT COMPOSITIONS | FAY, ZOHREH ALEMZADEH | 1617 | §103 | Non-Final OA | 4d overdue | Pending | Dec 18, 2023 |
| 18348543 | SOIL-BASED DNA EXTRACTION | GERIDO, DWAN A | 1797 | §103 | Final Rejection | 9d | Pending | Jul 07, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial